Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.

Clinical trial NCT00317161 · COMPLETED

Trial details

NCT number: NCT00317161
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Hepatitis B Haemophilus Influenzae Type b Whole Cell Pertussis Tetanus

Start date: 2004-08-01
Primary completion: 2005-04-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.